Roche Holding AG said an experimental breast-cancer treatment will get an expedited review from US regulators after showing ...
By Pierre Bertrand Roche said that the U.S. Food and Drug Administration has designated its Inavolisib breast cancer treatment as a breakthrough therapy.
The US Food and Drug Administration (FDA) has granted Roche a breakthrough therapy designation for its breast cancer therapy ...
Roche RHHBY obtained a Breakthrough Therapy Designation for its investigational oral therapy inavolisib for treating adult ...
(RTTNews) - Swiss drug major Roche Holding AG (RHHBY) and its U.S. Unit Genentech announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for ...
J&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority Review tags to Sanofi's (SNY ...
Another reason the drug will become standard of care in this setting ... ASCO's Chief Medical Officer Julie Gralow, MD, a ...
Roche said an experimental breast-cancer treatment will get an expedited review from US regulators after showing it helped ...
Roche is valued attractively ... Data on an obesity drug in development is encouraging, but it needs to be differentiated from other treatments on the market, Berenberg said. Likewise, several ...